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Abstract 
AKT and its substrate BAD promote prostate cancer cell survival. Agonists, such as 
carbachol, and hormones that increase intracellular calcium concentration can activate 
AKT leading to cancer cell survival. LNCaP prostate cancer cells express the carbachol-
sensitive M3-subtype of GPCR’s that increase intracellular calcium and activate the 
family of Ca2+/Calmodulin-dependent Protein Kinases (CaM Ks). One type of CaM 
Kinase, CaM Kinase Kinase (CaM KK), directly phosphorylates AKT on threonine 308. AKT 
phosphorylation and activation can enhance cell survival through phosphorylation BAD 
protein and the subsequent blockade of caspase activation. Our goals were to examine 
the mechanism of carbachol activation of AKT and BAD in LNCaP prostate cancer cells 
and evaluate whether CaM KK may be mediating carbachol’s activation of AKT and cell 
survival. The results suggest that carbachol triggered phosphorylation of both AKT and 
BAD in LNCaP cells. AKT and BAD phosphorylation were blocked by the selective CaM KK 
inhibitor, STO-609, as well as siRNA directed against CaM KK. Taken together this data 
suggests a role for CaM KK in the pathway. In addition, the bacterial toxin anisomycin 
triggered caspase activation in LNCaP cells that was blocked by carbachol treatment. 
Finally, our results suggest that carbachol treatment of LNCaP cells promoted cell 
survival through CaM KK and its phosphorylation of AKT. 
